Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReCOV Phase 2 COVID-19 Vaccine Trial
NCT05084989Phase 2Completed
- Sponsor
- Recbio
- Start
- Jan 2022
- Primary completion
- Aug 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ReCOV in coronavirus disease 2019 (COVID-19), sponsored by Recbio. Started Jan 2022; status: completed.
02
Drugs
ReCOV
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05084989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05084989.